Joint Pain Injection Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Injection (Hyaluronic Acid Injections, Corticosteroid Injections, Others); Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, Others); Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Others) and Geography
Report Code: TIPRE00003536 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Joint pain injections are medicinal fluids inserted in the body of patients to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.
MARKET DYNAMICS
The joint pain injection market is anticipated to grow in the forecast, owing to increasing prevalence of the osteoporosis, rise in the elderly population, increasing prevalence of the rheumatoid arthritis and others. The advancement in the field of pharmaceutical and orthobiologics are likely to create growth opportunities for the joint pain injection market.
MARKET SCOPE
The "Global Joint Pain Injection Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical with a special focus on the global market trend analysis. The report aims to provide an overview of joint pain injection market with detailed market segmentation by injection, joint type, distribution channel and geography. The global joint pain injection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Joint pain injection market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global joint pain injection market is segmented on the basis of injection, joint type and distribution channel. Based on the injection segment the market is classified as hyaluronic acid injections, corticosteroid injections and others. On the basis of joint type the market is segmented as knee, foot and ankle, shoulder and elbow, hip and others. Based on distribution channel the market is classified as retail pharmacies, hospitals pharmacies and others.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Joint pain injection market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The joint pain injection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting joint pain injection market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the joint pain injection market in these regions.
MARKET PLAYERS
The reports cover key developments in the Joint pain injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from joint pain injection market are anticipated to lucrative growth opportunities in the future with the rising demand for Joint pain injection market in the global market. Below mentioned is the list of few companies engaged in the joint pain injection market.
The report also includes the profiles of key joint pain injection market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Joint pain injections are medicinal fluids inserted in the body of patients to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.
MARKET DYNAMICS
The joint pain injection market is anticipated to grow in the forecast, owing to increasing prevalence of the osteoporosis, rise in the elderly population, increasing prevalence of the rheumatoid arthritis and others. The advancement in the field of pharmaceutical and orthobiologics are likely to create growth opportunities for the joint pain injection market.
MARKET SCOPE
The "Global Joint Pain Injection Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical with a special focus on the global market trend analysis. The report aims to provide an overview of joint pain injection market with detailed market segmentation by injection, joint type, distribution channel and geography. The global joint pain injection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Joint pain injection market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global joint pain injection market is segmented on the basis of injection, joint type and distribution channel. Based on the injection segment the market is classified as hyaluronic acid injections, corticosteroid injections and others. On the basis of joint type the market is segmented as knee, foot and ankle, shoulder and elbow, hip and others. Based on distribution channel the market is classified as retail pharmacies, hospitals pharmacies and others.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Joint pain injection market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The joint pain injection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting joint pain injection market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the joint pain injection market in these regions.
MARKET PLAYERS
The reports cover key developments in the Joint pain injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from joint pain injection market are anticipated to lucrative growth opportunities in the future with the rising demand for Joint pain injection market in the global market. Below mentioned is the list of few companies engaged in the joint pain injection market.
The report also includes the profiles of key joint pain injection market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Sanofi-aventis U.S. LLC, a Sanofi Company
- Pnika Therapeutics, Inc.
- Chugai Pharmaceutical Co., Ltd
- Ferring B.V
- Biovefizer Inc
- Antus
- Fidia Pharma USA, Inc
- Zimmer Biomet Holdings, Inc.
- Flexion Therapeutics, Inc
- Seikagaku Corporation
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Joint Pain Injection Market - By Injection
1.3.2 Joint Pain Injection Market - By Joint Type
1.3.3 Joint Pain Injection Market - By Distribution Channel
1.3.4 Joint Pain Injection Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. JOINT PAIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. JOINT PAIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. JOINT PAIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. JOINT PAIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. JOINT PAIN INJECTION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - INJECTION
7.1. OVERVIEW
7.2. INJECTION MARKET FORECASTS AND ANALYSIS
7.3. HYALURONIC ACID INJECTIONS
7.3.1. Overview
7.3.2. Hyaluronic Acid Injections Market Forecast and Analysis
7.4. CORTICOSTEROID INJECTIONS
7.4.1. Overview
7.4.2. Corticosteroid Injections Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - JOINT TYPE
8.1. OVERVIEW
8.2. JOINT TYPE MARKET FORECASTS AND ANALYSIS
8.3. KNEE
8.3.1. Overview
8.3.2. Knee Market Forecast and Analysis
8.4. FOOT AND ANKLE
8.4.1. Overview
8.4.2. Foot and Ankle Market Forecast and Analysis
8.5. SHOULDER AND ELBOW
8.5.1. Overview
8.5.2. Shoulder and Elbow Market Forecast and Analysis
8.6. HIP
8.6.1. Overview
8.6.2. Hip Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITALS PHARMACIES
9.4.1. Overview
9.4.2. Hospitals Pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. JOINT PAIN INJECTION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Joint Pain Injection Market Overview
10.1.2 North America Joint Pain Injection Market Forecasts and Analysis
10.1.3 North America Joint Pain Injection Market Forecasts and Analysis - By Injection
10.1.4 North America Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.1.5 North America Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Joint Pain Injection Market Forecasts and Analysis - By Countries
10.1.6.1 United States Joint Pain Injection Market
10.1.6.1.1 United States Joint Pain Injection Market by Injection
10.1.6.1.2 United States Joint Pain Injection Market by Joint Type
10.1.6.1.3 United States Joint Pain Injection Market by Distribution Channel
10.1.6.2 Canada Joint Pain Injection Market
10.1.6.2.1 Canada Joint Pain Injection Market by Injection
10.1.6.2.2 Canada Joint Pain Injection Market by Joint Type
10.1.6.2.3 Canada Joint Pain Injection Market by Distribution Channel
10.1.6.3 Mexico Joint Pain Injection Market
10.1.6.3.1 Mexico Joint Pain Injection Market by Injection
10.1.6.3.2 Mexico Joint Pain Injection Market by Joint Type
10.1.6.3.3 Mexico Joint Pain Injection Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Joint Pain Injection Market Overview
10.2.2 Europe Joint Pain Injection Market Forecasts and Analysis
10.2.3 Europe Joint Pain Injection Market Forecasts and Analysis - By Injection
10.2.4 Europe Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.2.5 Europe Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Joint Pain Injection Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Joint Pain Injection Market
10.2.6.1.1 Germany Joint Pain Injection Market by Injection
10.2.6.1.2 Germany Joint Pain Injection Market by Joint Type
10.2.6.1.3 Germany Joint Pain Injection Market by Distribution Channel
10.2.6.2 France Joint Pain Injection Market
10.2.6.2.1 France Joint Pain Injection Market by Injection
10.2.6.2.2 France Joint Pain Injection Market by Joint Type
10.2.6.2.3 France Joint Pain Injection Market by Distribution Channel
10.2.6.3 Italy Joint Pain Injection Market
10.2.6.3.1 Italy Joint Pain Injection Market by Injection
10.2.6.3.2 Italy Joint Pain Injection Market by Joint Type
10.2.6.3.3 Italy Joint Pain Injection Market by Distribution Channel
10.2.6.4 Spain Joint Pain Injection Market
10.2.6.4.1 Spain Joint Pain Injection Market by Injection
10.2.6.4.2 Spain Joint Pain Injection Market by Joint Type
10.2.6.4.3 Spain Joint Pain Injection Market by Distribution Channel
10.2.6.5 United Kingdom Joint Pain Injection Market
10.2.6.5.1 United Kingdom Joint Pain Injection Market by Injection
10.2.6.5.2 United Kingdom Joint Pain Injection Market by Joint Type
10.2.6.5.3 United Kingdom Joint Pain Injection Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Joint Pain Injection Market Overview
10.3.2 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis
10.3.3 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Injection
10.3.4 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.3.5 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Joint Pain Injection Market
10.3.6.1.1 Australia Joint Pain Injection Market by Injection
10.3.6.1.2 Australia Joint Pain Injection Market by Joint Type
10.3.6.1.3 Australia Joint Pain Injection Market by Distribution Channel
10.3.6.2 China Joint Pain Injection Market
10.3.6.2.1 China Joint Pain Injection Market by Injection
10.3.6.2.2 China Joint Pain Injection Market by Joint Type
10.3.6.2.3 China Joint Pain Injection Market by Distribution Channel
10.3.6.3 India Joint Pain Injection Market
10.3.6.3.1 India Joint Pain Injection Market by Injection
10.3.6.3.2 India Joint Pain Injection Market by Joint Type
10.3.6.3.3 India Joint Pain Injection Market by Distribution Channel
10.3.6.4 Japan Joint Pain Injection Market
10.3.6.4.1 Japan Joint Pain Injection Market by Injection
10.3.6.4.2 Japan Joint Pain Injection Market by Joint Type
10.3.6.4.3 Japan Joint Pain Injection Market by Distribution Channel
10.3.6.5 South Korea Joint Pain Injection Market
10.3.6.5.1 South Korea Joint Pain Injection Market by Injection
10.3.6.5.2 South Korea Joint Pain Injection Market by Joint Type
10.3.6.5.3 South Korea Joint Pain Injection Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Joint Pain Injection Market Overview
10.4.2 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis
10.4.3 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Injection
10.4.4 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.4.5 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Joint Pain Injection Market
10.4.6.1.1 South Africa Joint Pain Injection Market by Injection
10.4.6.1.2 South Africa Joint Pain Injection Market by Joint Type
10.4.6.1.3 South Africa Joint Pain Injection Market by Distribution Channel
10.4.6.2 Saudi Arabia Joint Pain Injection Market
10.4.6.2.1 Saudi Arabia Joint Pain Injection Market by Injection
10.4.6.2.2 Saudi Arabia Joint Pain Injection Market by Joint Type
10.4.6.2.3 Saudi Arabia Joint Pain Injection Market by Distribution Channel
10.4.6.3 U.A.E Joint Pain Injection Market
10.4.6.3.1 U.A.E Joint Pain Injection Market by Injection
10.4.6.3.2 U.A.E Joint Pain Injection Market by Joint Type
10.4.6.3.3 U.A.E Joint Pain Injection Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Joint Pain Injection Market Overview
10.5.2 South and Central America Joint Pain Injection Market Forecasts and Analysis
10.5.3 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Injection
10.5.4 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.5.5 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Joint Pain Injection Market
10.5.6.1.1 Brazil Joint Pain Injection Market by Injection
10.5.6.1.2 Brazil Joint Pain Injection Market by Joint Type
10.5.6.1.3 Brazil Joint Pain Injection Market by Distribution Channel
10.5.6.2 Argentina Joint Pain Injection Market
10.5.6.2.1 Argentina Joint Pain Injection Market by Injection
10.5.6.2.2 Argentina Joint Pain Injection Market by Joint Type
10.5.6.2.3 Argentina Joint Pain Injection Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. JOINT PAIN INJECTION MARKET, KEY COMPANY PROFILES
12.1. SANOFI-AVENTIS U.S. LLC, A SANOFI COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ANIKA THERAPEUTICS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CHUGAI PHARMACEUTICAL CO., LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FERRING B.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOVENTUS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. FIDIA PHARMA USA, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ZIMMER BIOMET HOLDINGS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FLEXION THERAPEUTICS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SEIKAGAKU CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Joint Pain Injection Market - By Injection
1.3.2 Joint Pain Injection Market - By Joint Type
1.3.3 Joint Pain Injection Market - By Distribution Channel
1.3.4 Joint Pain Injection Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. JOINT PAIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. JOINT PAIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. JOINT PAIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. JOINT PAIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. JOINT PAIN INJECTION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - INJECTION
7.1. OVERVIEW
7.2. INJECTION MARKET FORECASTS AND ANALYSIS
7.3. HYALURONIC ACID INJECTIONS
7.3.1. Overview
7.3.2. Hyaluronic Acid Injections Market Forecast and Analysis
7.4. CORTICOSTEROID INJECTIONS
7.4.1. Overview
7.4.2. Corticosteroid Injections Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - JOINT TYPE
8.1. OVERVIEW
8.2. JOINT TYPE MARKET FORECASTS AND ANALYSIS
8.3. KNEE
8.3.1. Overview
8.3.2. Knee Market Forecast and Analysis
8.4. FOOT AND ANKLE
8.4.1. Overview
8.4.2. Foot and Ankle Market Forecast and Analysis
8.5. SHOULDER AND ELBOW
8.5.1. Overview
8.5.2. Shoulder and Elbow Market Forecast and Analysis
8.6. HIP
8.6.1. Overview
8.6.2. Hip Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. JOINT PAIN INJECTION MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITALS PHARMACIES
9.4.1. Overview
9.4.2. Hospitals Pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. JOINT PAIN INJECTION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Joint Pain Injection Market Overview
10.1.2 North America Joint Pain Injection Market Forecasts and Analysis
10.1.3 North America Joint Pain Injection Market Forecasts and Analysis - By Injection
10.1.4 North America Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.1.5 North America Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Joint Pain Injection Market Forecasts and Analysis - By Countries
10.1.6.1 United States Joint Pain Injection Market
10.1.6.1.1 United States Joint Pain Injection Market by Injection
10.1.6.1.2 United States Joint Pain Injection Market by Joint Type
10.1.6.1.3 United States Joint Pain Injection Market by Distribution Channel
10.1.6.2 Canada Joint Pain Injection Market
10.1.6.2.1 Canada Joint Pain Injection Market by Injection
10.1.6.2.2 Canada Joint Pain Injection Market by Joint Type
10.1.6.2.3 Canada Joint Pain Injection Market by Distribution Channel
10.1.6.3 Mexico Joint Pain Injection Market
10.1.6.3.1 Mexico Joint Pain Injection Market by Injection
10.1.6.3.2 Mexico Joint Pain Injection Market by Joint Type
10.1.6.3.3 Mexico Joint Pain Injection Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Joint Pain Injection Market Overview
10.2.2 Europe Joint Pain Injection Market Forecasts and Analysis
10.2.3 Europe Joint Pain Injection Market Forecasts and Analysis - By Injection
10.2.4 Europe Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.2.5 Europe Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Joint Pain Injection Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Joint Pain Injection Market
10.2.6.1.1 Germany Joint Pain Injection Market by Injection
10.2.6.1.2 Germany Joint Pain Injection Market by Joint Type
10.2.6.1.3 Germany Joint Pain Injection Market by Distribution Channel
10.2.6.2 France Joint Pain Injection Market
10.2.6.2.1 France Joint Pain Injection Market by Injection
10.2.6.2.2 France Joint Pain Injection Market by Joint Type
10.2.6.2.3 France Joint Pain Injection Market by Distribution Channel
10.2.6.3 Italy Joint Pain Injection Market
10.2.6.3.1 Italy Joint Pain Injection Market by Injection
10.2.6.3.2 Italy Joint Pain Injection Market by Joint Type
10.2.6.3.3 Italy Joint Pain Injection Market by Distribution Channel
10.2.6.4 Spain Joint Pain Injection Market
10.2.6.4.1 Spain Joint Pain Injection Market by Injection
10.2.6.4.2 Spain Joint Pain Injection Market by Joint Type
10.2.6.4.3 Spain Joint Pain Injection Market by Distribution Channel
10.2.6.5 United Kingdom Joint Pain Injection Market
10.2.6.5.1 United Kingdom Joint Pain Injection Market by Injection
10.2.6.5.2 United Kingdom Joint Pain Injection Market by Joint Type
10.2.6.5.3 United Kingdom Joint Pain Injection Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Joint Pain Injection Market Overview
10.3.2 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis
10.3.3 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Injection
10.3.4 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.3.5 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Joint Pain Injection Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Joint Pain Injection Market
10.3.6.1.1 Australia Joint Pain Injection Market by Injection
10.3.6.1.2 Australia Joint Pain Injection Market by Joint Type
10.3.6.1.3 Australia Joint Pain Injection Market by Distribution Channel
10.3.6.2 China Joint Pain Injection Market
10.3.6.2.1 China Joint Pain Injection Market by Injection
10.3.6.2.2 China Joint Pain Injection Market by Joint Type
10.3.6.2.3 China Joint Pain Injection Market by Distribution Channel
10.3.6.3 India Joint Pain Injection Market
10.3.6.3.1 India Joint Pain Injection Market by Injection
10.3.6.3.2 India Joint Pain Injection Market by Joint Type
10.3.6.3.3 India Joint Pain Injection Market by Distribution Channel
10.3.6.4 Japan Joint Pain Injection Market
10.3.6.4.1 Japan Joint Pain Injection Market by Injection
10.3.6.4.2 Japan Joint Pain Injection Market by Joint Type
10.3.6.4.3 Japan Joint Pain Injection Market by Distribution Channel
10.3.6.5 South Korea Joint Pain Injection Market
10.3.6.5.1 South Korea Joint Pain Injection Market by Injection
10.3.6.5.2 South Korea Joint Pain Injection Market by Joint Type
10.3.6.5.3 South Korea Joint Pain Injection Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Joint Pain Injection Market Overview
10.4.2 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis
10.4.3 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Injection
10.4.4 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.4.5 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Joint Pain Injection Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Joint Pain Injection Market
10.4.6.1.1 South Africa Joint Pain Injection Market by Injection
10.4.6.1.2 South Africa Joint Pain Injection Market by Joint Type
10.4.6.1.3 South Africa Joint Pain Injection Market by Distribution Channel
10.4.6.2 Saudi Arabia Joint Pain Injection Market
10.4.6.2.1 Saudi Arabia Joint Pain Injection Market by Injection
10.4.6.2.2 Saudi Arabia Joint Pain Injection Market by Joint Type
10.4.6.2.3 Saudi Arabia Joint Pain Injection Market by Distribution Channel
10.4.6.3 U.A.E Joint Pain Injection Market
10.4.6.3.1 U.A.E Joint Pain Injection Market by Injection
10.4.6.3.2 U.A.E Joint Pain Injection Market by Joint Type
10.4.6.3.3 U.A.E Joint Pain Injection Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Joint Pain Injection Market Overview
10.5.2 South and Central America Joint Pain Injection Market Forecasts and Analysis
10.5.3 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Injection
10.5.4 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Joint Type
10.5.5 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Joint Pain Injection Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Joint Pain Injection Market
10.5.6.1.1 Brazil Joint Pain Injection Market by Injection
10.5.6.1.2 Brazil Joint Pain Injection Market by Joint Type
10.5.6.1.3 Brazil Joint Pain Injection Market by Distribution Channel
10.5.6.2 Argentina Joint Pain Injection Market
10.5.6.2.1 Argentina Joint Pain Injection Market by Injection
10.5.6.2.2 Argentina Joint Pain Injection Market by Joint Type
10.5.6.2.3 Argentina Joint Pain Injection Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. JOINT PAIN INJECTION MARKET, KEY COMPANY PROFILES
12.1. SANOFI-AVENTIS U.S. LLC, A SANOFI COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ANIKA THERAPEUTICS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CHUGAI PHARMACEUTICAL CO., LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FERRING B.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOVENTUS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. FIDIA PHARMA USA, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ZIMMER BIOMET HOLDINGS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FLEXION THERAPEUTICS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SEIKAGAKU CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Sanofi-aventis U.S. LLC, a Sanofi Company
2. Pfizer Inc
3. Anika Therapeutics, Inc.
4. Chugai Pharmaceutical Co., Ltd
5. Ferring B.V
6. Bioventus
7. Fidia Pharma USA, Inc
8. Zimmer Biomet Holdings, Inc.
9. Flexion Therapeutics, Inc
10. Seikagaku Corporation
1. Sanofi-aventis U.S. LLC, a Sanofi Company
2. Pfizer Inc
3. Anika Therapeutics, Inc.
4. Chugai Pharmaceutical Co., Ltd
5. Ferring B.V
6. Bioventus
7. Fidia Pharma USA, Inc
8. Zimmer Biomet Holdings, Inc.
9. Flexion Therapeutics, Inc
10. Seikagaku Corporation